LAVIOR Debuts Revolutionary New Formula for Wound Care and Chronic Skin Conditions
Las Vegas, NV -- (ReleaseWire) -- 07/18/2018 --LAVIOR, a Las Vegas, Nevada-based company, announced its breakthrough formula utilizing groundbreaking technology for the care and management of chronic wounds and inflammatory skin conditions. LAVIOR is the first company to use the AGS BOTANICAL, a proprietary extract for all-in-one wound care solutions and to address the biggest problem of biofilm and inflammation.
"The reason that LAVIOR is so exciting is that antibiotics and silver-based products are becoming ineffective at fighting resistant bacteria" said Anabelle Savion, LAVIOR Co-Founder and EVP Marketing. "LAVIOR D-Care and W-Care have been clinically proven to work on non-healing chronic wounds, and to be an all-in-one solution due to their antibacterial and anti-inflammatory action."
The introduction of LAVIOR is particularly important as it comes at a time when many pharmacological drugs have lost their efficacy to treat common conditions ranging from viral, bacterial and fungal infections to diabetic ulcers. LAVIOR D-Care and W-Care are novel ointments that have been proven to reduce infection and accelerate healing and have become the leading non-graft wound care/ulcer treatments used by physicians treating foot, ankle and lower extremity conditions.
The LAVIOR formula offers a multi-faceted solution encompassing a wealth of natural properties. It's a strong anti-inflammatory with powerful antibacterial, antifungal and antiviral abilities. LAVIOR wound care products disrupt the contaminated bacterial and fungal environment, known as "the wound biofilm", and thus shorten the inflammatory stage for quicker healing.
Applying LAVIOR D-CARE or W-CARE on wounds creates the optimal environment for wound auto-debridement and regeneration. LAVIOR products provide auto-debridement by softening the eschar and stimulating the circulation, especially in chronic wounds. They work as a Cox-2 inhibitor and reduce secretions of cytokines, thereby decreasing inflammation and pain. Backed by eight years of research and development, they are steroid-free, cruelty-free, vegan-friendly and contain no parabens or fragrances.
Established in 2013 by Anabelle and Gilad Savion, LAVIOR develops breakthrough plant based natural treatments for diabetic ulcers, viral and inflammatory skin conditions. The skincare line soothes and heals some of the most widespread and challenging skin problems. Using its proprietary extract, AGS BOTANICAL, LAVIOR is creating new generations of high-potency formulas to address skin issues.
International Skincare Brand LAVIOR Taps Affective Markets for AI-Driven Market Validation
Affective Markets’ AI-based mapping tool for brands enables efficient and accurate measurement of consumer sentiment.
NEW YORK (PRWEB) DECEMBER 04, 2019
LAVIOR, a leading international pharmaceutical company developing natural products for challenging skin conditions, has tapped Affective Markets for an artificial intelligence-driven assessment of the North American market; leveraging the results as a validation of their North American product rollout strategy.
As a way to predict consumers’ emotional responses to LAVIOR’s product line in the marketplace, Affective Markets ran the company’s visual identity (Branding, packaging and marketing messages) through its AI-driven Emotion DNA™ technology, comparing these assets with established skincare competitors. Their findings gave LAVIOR’s marketing and distribution teams valuable insights into consumer emotional reaction in the market and crucial market intel for a better understanding of their audience and sustained growth.
Affective Markets’ SaaS system all but eliminates the need for expensive market research, which can take weeks to compile and can draw tens of thousands of dollars worth of marketing budget. Affective Markets’ AI provides reliable, actionable results in a matter of hours and at a fraction of the cost.
“Affective Markets helped my company better understand our competitors’ positioning in the US market, consumer perceptions of our own products, and the potential effects of consumer emotional purchasing behavior,” said Anabelle Savion, LAVIOR Co-Founder & EVP of Marketing. “We see Affective Markets as the future of Marketing R&D. It’s an essential platform for any company starting a new brand or looking to improve their branding and positioning.”
Affective Markets’ AI-based system effectively replaces real-world polling and focus-grouping by instead querying their database of thousands of digital profiles. Affective Markets’ AI leverages tens of thousands of anonymized digital profiles, created after individual consumers answer a series of one-time questions and share their preferences on a variety of queries. In this way, they’re able to provide a market-based assessment of any new brand, product, or marketing campaign within a matter of hours.
“In truth, people almost always buy based on emotion and then justify their purchases with logic after-the-fact. What we’ve created is the first AI-based system for capturing and measuring that kind of ‘gut reaction’ decision-making,” explained Dr. Dan Gang, Founder, and CEO of Affective Markets.
Quick, emotional decisions are referred to as System 1 thinking by psychologists and it’s the kind of process that people use to make hundreds of key decisions every day. Affective Markets’ AI can extract emotional insights from these answers and construct digital profiles for the consumer set, which are used again and again to assess new campaigns in specific regional markets, broken out into an AM score.
“Because so-called ‘rational,’ System 2 thinking is based on so many different factors, it’s virtually impossible to predict answers with any degree of accuracy,” added Dr. Gang. “But System 1 thinking happens at such a deep, subconscious level that it’s possible for AI to predict future behavior based on previous decisions. Most consumer purchasing decisions are made this way, in fact. Therefore, we can offer a very high degree of accuracy using AI. That offers a huge benefit to innovative companies like LAVIOR.”
“We consider Affective Markets a trusted business partner and plan to continue our working relationship with them,” added Savion. “They’re able to take the mystery out of marketing products in any new region. Affective Markets helped us fine-tune and strengthen our branding and positioning with a level of insight we wouldn’t otherwise have had.”
LAVIOR Inc. is a natural pharmaceutical company, pioneering breakthrough plant-based natural treatments for wounds, viral and inflammatory skin conditions. The skincare line soothes and heals some of the most widespread and challenging skin problems. Using its proprietary extract, LAVIOR is creating new generations of high-potency formulas to address skin issues. All LAVIOR products are manufactured in the U.S. in an FDA-certified facility, are FDA OTC drugs and dermatology-tested. The products are sold online at http://www.lavior.com, at Amazon.com, Walmart.com, Ebay.com as well as selected retailers, pharmacies and medical practices across the country.
About Affective Markets
Based in Tel Aviv and New York City, Affective Markets has developed an Artificial Intelligence platform that is capable of extracting emotional insights from data, or Emotion DNA™. Perfect for assessing consumers’ emotional sentiment about products, brands, marketing campaigns, and design, Affective Markets’ AI-driven insights are used by top brands all over the globe to i